TORRENT PHARMACEUTICALS
|
TORRENT PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹16,705 Cr | ₹16,321 Cr | ₹15,211 Cr | ₹14,878 Cr | ₹14,953 Cr |
| Sales | ₹16,540 Cr | ₹16,164 Cr | ₹15,122 Cr | ₹14,760 Cr | ₹14,794 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹166 Cr | ₹156 Cr | ₹89 Cr | ₹118 Cr | ₹159 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹10,728 Cr | ₹9,620 Cr | ₹8,508 Cr | ₹8,005 Cr | ₹7,939 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-155 Cr | ₹166 Cr | ₹74 Cr | ₹-279 Cr | ₹-133 Cr |
| Raw Material Consumed | ₹2,614 Cr | ₹2,347 Cr | ₹2,157 Cr | ₹2,239 Cr | ₹2,115 Cr |
| Opening Raw Materials | ₹752 Cr | ₹841 Cr | ₹985 Cr | ₹741 Cr | ₹664 Cr |
| Purchases Raw Materials | ₹1,308 Cr | ₹1,170 Cr | ₹1,182 Cr | ₹1,478 Cr | ₹1,270 Cr |
| Closing Raw Materials | ₹630 Cr | ₹752 Cr | ₹841 Cr | ₹985 Cr | ₹741 Cr |
| Other Direct Purchases / Brought in cost | ₹1,184 Cr | ₹1,089 Cr | ₹831 Cr | ₹1,005 Cr | ₹923 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹145 Cr | ₹155 Cr | ₹144 Cr | ₹123 Cr | ₹128 Cr |
| Electricity & Power | ₹145 Cr | ₹155 Cr | ₹144 Cr | ₹123 Cr | ₹128 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹1,984 Cr | ₹1,678 Cr | ₹1,526 Cr | ₹1,440 Cr | ₹1,429 Cr |
| Salaries, Wages & Bonus | ₹1,695 Cr | ₹1,433 Cr | ₹1,305 Cr | ₹1,245 Cr | ₹1,233 Cr |
| Contributions to EPF & Pension Funds | ₹178 Cr | ₹153 Cr | ₹134 Cr | ₹118 Cr | ₹123 Cr |
| Workmen and Staff Welfare Expenses | ₹77 Cr | ₹63 Cr | ₹60 Cr | ₹49 Cr | ₹51 Cr |
| Other Employees Cost | ₹34 Cr | ₹29 Cr | ₹28 Cr | ₹26 Cr | ₹22 Cr |
| Other Manufacturing Expenses | ₹571 Cr | ₹571 Cr | ₹591 Cr | ₹551 Cr | ₹544 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹96 Cr | ₹84 Cr | ₹88 Cr | ₹75 Cr | ₹51 Cr |
| Repairs and Maintenance | - | - | - | - | - |
| Packing Material Consumed | ₹227 Cr | ₹222 Cr | ₹211 Cr | ₹186 Cr | ₹185 Cr |
| Other Mfg Exp | ₹248 Cr | ₹265 Cr | ₹292 Cr | ₹290 Cr | ₹308 Cr |
| General and Administration Expenses | ₹981 Cr | ₹775 Cr | ₹638 Cr | ₹633 Cr | ₹802 Cr |
| Rent , Rates & Taxes | - | - | - | - | - |
| Insurance | - | - | - | - | - |
| Printing and stationery | - | - | - | - | - |
| Professional and legal fees | ₹185 Cr | ₹137 Cr | ₹111 Cr | ₹140 Cr | ₹88 Cr |
| Traveling and conveyance | ₹206 Cr | ₹158 Cr | ₹82 Cr | ₹62 Cr | ₹108 Cr |
| Other Administration | ₹590 Cr | ₹480 Cr | ₹445 Cr | ₹432 Cr | ₹606 Cr |
| Selling and Distribution Expenses | ₹1,130 Cr | ₹1,027 Cr | ₹885 Cr | ₹743 Cr | ₹807 Cr |
| Advertisement & Sales Promotion | - | - | - | - | - |
| Sales Commissions & Incentives | - | - | - | - | - |
| Freight and Forwarding | - | - | - | - | - |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹1,130 Cr | ₹1,027 Cr | ₹885 Cr | ₹743 Cr | ₹807 Cr |
| Miscellaneous Expenses | ₹95 Cr | ₹77 Cr | ₹62 Cr | ₹75 Cr | ₹76 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | ₹7.08 Cr | ₹2.27 Cr | ₹0.90 Cr | ₹14 Cr | - |
| Losson disposal of fixed assets(net) | ₹0.02 Cr | - | - | - | - |
| Losson foreign exchange fluctuations | ₹3.91 Cr | ₹18 Cr | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹84 Cr | ₹57 Cr | ₹61 Cr | ₹60 Cr | ₹76 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹7,364 Cr | ₹6,796 Cr | ₹6,077 Cr | ₹5,524 Cr | ₹5,769 Cr |
| Operating Profit (Excl OI) | ₹3,364 Cr | ₹2,824 Cr | ₹2,431 Cr | ₹2,480 Cr | ₹2,170 Cr |
| Other Income | ₹62 Cr | ₹63 Cr | ₹197 Cr | ₹57 Cr | ₹121 Cr |
| Interest Received | ₹11 Cr | ₹15 Cr | ₹7.15 Cr | ₹5.07 Cr | ₹7.96 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | ₹22 Cr | - | - | - |
| Profits on sale of Investments | ₹18 Cr | ₹19 Cr | ₹9.88 Cr | ₹16 Cr | ₹29 Cr |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | - | - | ₹170 Cr | ₹32 Cr | ₹83 Cr |
| Others | ₹32 Cr | ₹7.45 Cr | ₹9.99 Cr | ₹4.37 Cr | ₹1.40 Cr |
| Operating Profit | ₹3,426 Cr | ₹2,887 Cr | ₹2,628 Cr | ₹2,537 Cr | ₹2,292 Cr |
| Interest | ₹354 Cr | ₹333 Cr | ₹255 Cr | ₹353 Cr | ₹451 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹0.93 Cr | ₹1.20 Cr | ₹2.13 Cr | ₹2.12 Cr | ₹2.35 Cr |
| Other Interest | ₹353 Cr | ₹332 Cr | ₹253 Cr | ₹351 Cr | ₹448 Cr |
| PBDT | ₹3,072 Cr | ₹2,554 Cr | ₹2,373 Cr | ₹2,184 Cr | ₹1,841 Cr |
| Depreciation | ₹808 Cr | ₹707 Cr | ₹662 Cr | ₹658 Cr | ₹654 Cr |
| Profit Before Taxation & Exceptional Items | ₹2,264 Cr | ₹1,847 Cr | ₹1,711 Cr | ₹1,526 Cr | ₹1,187 Cr |
| Exceptional Income / Expenses | ₹88 Cr | - | ₹-485 Cr | - | - |
| Profit Before Tax | ₹2,352 Cr | ₹1,847 Cr | ₹1,226 Cr | ₹1,526 Cr | ₹1,187 Cr |
| Provision for Tax | ₹696 Cr | ₹602 Cr | ₹449 Cr | ₹274 Cr | ₹162 Cr |
| Current Income Tax | ₹470 Cr | ₹355 Cr | ₹346 Cr | ₹334 Cr | ₹260 Cr |
| Deferred Tax | ₹220 Cr | ₹228 Cr | ₹107 Cr | ₹-53 Cr | ₹-59 Cr |
| Other taxes | ₹4.98 Cr | ₹20 Cr | ₹-4.02 Cr | ₹-6.72 Cr | ₹-39 Cr |
| Profit After Tax | ₹1,656 Cr | ₹1,245 Cr | ₹777 Cr | ₹1,252 Cr | ₹1,025 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹1,656 Cr | ₹1,245 Cr | ₹777 Cr | ₹1,252 Cr | ₹1,025 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹3,303 Cr | ₹2,917 Cr | ₹2,806 Cr | ₹1,893 Cr | ₹1,616 Cr |
| Appropriations | ₹4,960 Cr | ₹4,162 Cr | ₹3,584 Cr | ₹3,145 Cr | ₹2,641 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | ₹125 Cr |
| Other Appropriation | ₹273 Cr | ₹385 Cr | ₹244 Cr | ₹-0.04 Cr | ₹81 Cr |
| Equity Dividend % | ₹560.00 | ₹440.00 | ₹960.00 | ₹700.00 | ₹640.00 |
| Earnings Per Share | ₹48.94 | ₹36.79 | ₹45.92 | ₹73.97 | ₹60.55 |
| Adjusted EPS | ₹48.94 | ₹36.79 | ₹22.96 | ₹36.99 | ₹30.27 |
Compare Income Statement of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹124,857.8 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
| MANKIND PHARMA | ₹92,581.7 Cr | -0.1% | -8.3% | -14% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -3.3% |
2.8% |
19.7% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses